Germany and France lead calls for global human cloning ban
This article was originally published in Clinica
Last week, the foreign ministers of Germany and France met to consider ways of promoting a worldwide ban on human cloning, through the United Nations. It is the latest evidence of growing consensus on the issue. Such legislation, it is thought, would go a long way to quelling the fears of those who believe that embryonic stem cell research raises the risks of human cloning taking place in unregulated countries.
You may also be interested in...
Months of pandemic-induced disruption to health care systems and freedom of movement undoubtedly carries a cost. For the biopharmaceutical industry, this can be mitigated by its essential role in providing therapeutic interventions and leading the fightback via prophylactic vaccines. This softens the blow somewhat, certainly compared to other industries that are fully exposed to COVID-19 headwinds.
RSNA is the next major global medtech event to be run under a virtual format this fall. Under COVID-19, the major medtechs are finding different ways to demonstrate value, as Royal Philips explains.
The European Court of Justice rules that CBD cannot be regarded as a narcotic as it is non-psychoactive and suggests that a French ban on the cannabinoid is contrary to EU law on the free movement of goods. Legal experts and industry hope the judgment will pave the way for a regulated European CBD market.